Maximizing the use of potential donors through increased rates of family approach for authorization.
donor family authorization
donor potential
health services and outcomes research
organ allocation
organ availability
organ procurement
organ procurement organization
solid organ transplantation
Journal
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
revised:
26
08
2022
received:
24
02
2022
accepted:
27
08
2022
pubmed:
6
9
2022
medline:
6
12
2022
entrez:
5
9
2022
Statut:
ppublish
Résumé
In the United States, a small proportion of potential deceased organ donor referrals lead to donation and recovery. Understanding variation in the processes involved between organ procurement organizations (OPOs) may help increase deceased donation and reduce the organ shortage. We studied 103 923 referrals from 10 OPOs from 2018 to 2019, of which 14.4% led to approach for authorization, 8.2% led to authorization, 5.1% led to organ recovery, and 4.8% led to transplantation. First-person authorization (FPA) was associated with threefold higher odds of donation (OR =
Identifiants
pubmed: 36062407
doi: 10.1111/ajt.17194
pii: S1600-6135(23)00035-7
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2834-2841Subventions
Organisme : NIDDK NIH HHS
ID : K01 DK114388
Pays : United States
Organisme : NIDDK NIH HHS
ID : K01 DK101677
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI144954
Pays : United States
Informations de copyright
© 2022 The American Society of Transplantation and the American Society of Transplant Surgeons.
Références
DeRoos LJ, Zhou Y, Marrero WJ, et al. Assessment of National Organ Donation Rates and organ procurement organization metrics. JAMA Surg. 2021;156(2):173-180.
Goldberg D, Kallan MJ, Fu L, et al. Changing metrics of organ procurement organization performance in order to increase organ donation rates in the United States. Am J Transplant. 2017;17(12):3183-3192.
Siminoff LA, Gardiner HM, Wilson-Genderson M, Shafer TJ. How inaccurate metrics Hide the true potential for organ donation in the United States. Prog Transplant. 2018;28(1):12-18.
Razdan M, Degenholtz HB, Kahn JM, Driessen J. Breakdown in the organ donation process and its effect on organ availability. J Transplant. 2015;2015:831501.
Doby BL, Boyarsky BJ, Gentry S, Segev DL. Improving OPO performance through national data availability. Am J Transplant. 2019;19(10):2675-2677.
Klassen DK, Edwards LB, Stewart DE, Glazier AK, Orlowski JP, Berg CL. The OPTN deceased donor potential study: implications for policy and practice. Am J Transplant. 2016;16(6):1707-1714.
Centers for Medicare and Medicaid Services. CMS Finalizes Policy that will Increase the Number of Available Lifesavings Organs by Holding Organ Procurement Organizations Accountable through Transparency and Competition [press release]. November 20 2020. Accessed July 18, 2022. https://www.cms.gov/newsroom/press-releases/cms-finalizes-policy-will-increase-number-available-lifesavings-organs-holding-organ-procurement
Mathur AK. New metrics to measure OPO performance are here: how do we ensure organizations receive feedback and improve organ donation? Am J Transplant. 2022;22(2):339-340.
Goldberg DS, French B, Abt PL, Gilroy RK. Increasing the number of organ transplants in the United States by optimizing donor authorization rates. Am J Transplant. 2015;15(8):2117-2125.
Singh JM, Ball IM, Hartwick M, et al. Factors associated with consent for organ donation: a retrospective population-based study. Can Med Assoc J. 2021;193(45):E1725-E1732.
Louis TA, Zeger SL. Effective communication of standard errors and confidence intervals. Biostatistics. 2009;10(1):1-2.
Schwandt H, Currie J, Bär M, et al. Inequality in mortality between Black and White Americans by age, place, and cause and in comparison to Europe, 1990 to 2018. Proc Natl Acad Sci U S A. 2021;118(40):e2104684118. doi: 10.1073/pnas.2104684118
Fenelon A. Geographic divergence in mortality in the United States. Population and Development Review. 2013;39(4):611-634.
Ojo AO, Pietroski RE, O'Connor K, McGowan JJ, Dickinson DM. Quantifying organ donation rates by donation service area. Am J Transplant. 2005;5(4p2):958-966.
Tencza C, Stokes A, Preston S. Factors responsible for mortality variation in the United States: a latent variable analysis. Demogr Res. 2014;21(2):27-70.
Murphy SLK, Kenneth D, Xu J, Arias E. Mortality in the United States, 2020. NCHS Data Brief, no 427. National Center for Health Statistics; 2021. doi:10.15620/cdc:112079
Benjamins MR, Silva A, Saiyed NS, De Maio FG. Comparison of all-cause mortality rates and inequities between black and white populations across the 30 most populous US cities. JAMA Netw Open. 2021;4(1):e2032086.
Donaldson SV, Thomas AN, Gillum RF, Mehari A. Geographic variation in racial disparities in mortality from influenza and pneumonia in the United States in the pre-coronavirus disease 2019 era. Chest. 2021;159(6):2183-2190.
Sheehy E, O'Connor KJ, Luskin RS, et al. Investigating geographic variation in mortality in the context of organ donation. Am J Transplant. 2012;12(6):1598-1602.
Carr BG, Branas CC, Metlay JP, Sullivan AF, Camargo CA Jr. Access to emergency care in the United States. Ann Emerg Med. 2009;54(2):261-269.